Leyden James J
Department of Dermatology, University of Pennsylvania Hospital, Philadelphia, USA.
Cutis. 2004 Oct;74(4 Suppl):9-15.
Topical tazarotene has shown superior efficacy over other topical retinoids, including adapalene and tretinoin, in the treatment of mild to moderate acne. A meta-analysis of data from 6 multicenter, double-blind, randomized comparative trials was performed to determine how patient characteristics influence the efficacy and tolerability of topical tazarotene. Data on 468 patients who used tazarotene 0.1% gel or cream once daily for 12 weeks were collected. Topical tazarotene was effective and well tolerated, regardless of patients' acne severity, skin type, sex, or ethnicity. In general, 'using the cream formulation rather than the gel formulation optimized tolerability. These results indicate that topical tazarotene 0.1% gel and cream are efficacious and well-tolerated treatment options for clearing acne vulgaris across a broad range of patients.
在治疗轻至中度痤疮方面,外用他扎罗汀已显示出优于其他外用维甲酸类药物(包括阿达帕林和维甲酸)的疗效。进行了一项对6项多中心、双盲、随机对照试验数据的荟萃分析,以确定患者特征如何影响外用他扎罗汀的疗效和耐受性。收集了468例患者的数据,这些患者每天使用一次0.1%他扎罗汀凝胶或乳膏,持续12周。无论患者的痤疮严重程度、皮肤类型、性别或种族如何,外用他扎罗汀均有效且耐受性良好。一般来说,使用乳膏剂型而非凝胶剂型可优化耐受性。这些结果表明,0.1%他扎罗汀凝胶和乳膏是治疗广泛患者寻常痤疮的有效且耐受性良好的治疗选择。